Stay updated on Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial
Sign up to get notified when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.

Latest updates to the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations section reorganized into a consolidated 'Locations' list including Arizona, Iowa, New York, Virginia, and Victoria, replacing separate 'XYZ Locations' headings; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe Publications section text was updated to clarify that publications are provided voluntarily by the study submitter and relate to the study results, and the revision label was updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe government funding operating-status notice was removed from the page. The study details and page structure remain unchanged.SummaryDifference0.4%

- Check64 days agoChange DetectedThe two screenshots show only minor formatting and layout adjustments; core study details, objectives, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedMajor update: version bumped to v3.2.0 and an important government operating status notice added; previous version v3.1.0 deleted.SummaryDifference4%

- Check100 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.